Literature DB >> 21258366

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.

Jung-Mao Hsu1, Chun-Te Chen, Chao-Kai Chou, Hsu-Ping Kuo, Long-Yuan Li, Chun-Yi Lin, Hong-Jen Lee, Ying-Nai Wang, Mo Liu, Hsin-Wei Liao, Bin Shi, Chien-Chen Lai, Mark T Bedford, Chang-Hai Tsai, Mien-Chie Hung.   

Abstract

Epidermal growth factor receptor (EGFR) can undergo post-translational modifications, including phosphorylation, glycosylation and ubiquitylation, leading to diverse physiological consequences and modulation of its biological activity. There is increasing evidence that methylation may parallel other post-translational modifications in the regulation of various biological processes. It is still not known, however, whether EGFR is regulated by this post-translational event. Here, we show that EGFR Arg 1175 is methylated by an arginine methyltransferase, PRMT5. Arg 1175 methylation positively modulates EGF-induced EGFR trans-autophosphorylation at Tyr 1173, which governs ERK activation. Abolishment of Arg 1175 methylation enhances EGF-stimulated ERK activation by reducing SHP1 recruitment to EGFR, resulting in augmented cell proliferation, migration and invasion of EGFR-expressing cells. Therefore, we propose a model in which the regulatory crosstalk between PRMT5-mediated Arg 1175 methylation and EGF-induced Tyr 1173 phosphorylation attenuates EGFR-mediated ERK activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258366      PMCID: PMC3048027          DOI: 10.1038/ncb2158

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  27 in total

Review 1.  Epidermal growth factor receptor signaling.

Authors:  S Bogdan; C Klämbt
Journal:  Curr Biol       Date:  2001-04-17       Impact factor: 10.834

2.  Cross-regulation of histone modifications.

Authors:  John A Latham; Sharon Y R Dent
Journal:  Nat Struct Mol Biol       Date:  2007-11-05       Impact factor: 15.369

3.  Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.

Authors:  S Li; A D Couvillon; B B Brasher; R A Van Etten
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.

Authors:  C Soler; C V Alvarez; L Beguinot; G Carpenter
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

5.  Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells.

Authors:  Y Okabayashi; Y Kido; T Okutani; Y Sugimoto; K Sakaguchi; M Kasuga
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

6.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.

Authors:  M Rozakis-Adcock; J McGlade; G Mbamalu; G Pelicci; R Daly; W Li; A Batzer; S Thomas; J Brugge; P G Pelicci; J Schlessinger; T Pawson
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

7.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.

Authors:  A G Batzer; D Rotin; J M Ureña; E Y Skolnik; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C.

Authors:  S Tomic; U Greiser; R Lammers; A Kharitonenkov; E Imyanitov; A Ullrich; F D Böhmer
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

9.  Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells.

Authors:  T Okutani; Y Okabayashi; Y Kido; Y Sugimoto; K Sakaguchi; K Matuoka; T Takenawa; M Kasuga
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation.

Authors:  Patrizia Sini; Angela Cannas; Anthony J Koleske; Pier Paolo Di Fiore; Giorgio Scita
Journal:  Nat Cell Biol       Date:  2004-02-22       Impact factor: 28.824

View more
  96 in total

Review 1.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 2.  Protein arginine methylation in parasitic protozoa.

Authors:  John C Fisk; Laurie K Read
Journal:  Eukaryot Cell       Date:  2011-06-17

3.  The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation.

Authors:  Ning Yin; Adrienne Lepp; Yongsheng Ji; Matthew Mortensen; Songwang Hou; Xiao-Mei Qi; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

Review 4.  Non-histone protein methylation as a regulator of cellular signalling and function.

Authors:  Kyle K Biggar; Shawn S-C Li
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-10       Impact factor: 94.444

5.  Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML.

Authors:  S Kaushik; F Liu; K J Veazey; G Gao; P Das; L F Neves; K Lin; Y Zhong; Y Lu; V Giuliani; M T Bedford; S D Nimer; M A Santos
Journal:  Leukemia       Date:  2017-06-30       Impact factor: 11.528

6.  PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch.

Authors:  Alexsandra B Espejo; Guozhen Gao; Karynne Black; Sitaram Gayatri; Nicolas Veland; Jeesun Kim; Taiping Chen; Marius Sudol; Cheryl Walker; Mark T Bedford
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

7.  HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules.

Authors:  Smarajit Bandyopadhyay; Daniel P Harris; Gregory N Adams; Gregory E Lause; Anne McHugh; Emily G Tillmaand; Angela Money; Belinda Willard; Paul L Fox; Paul E Dicorleto
Journal:  Mol Cell Biol       Date:  2012-01-23       Impact factor: 4.272

8.  PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.

Authors:  Hsin-Wei Liao; Jung-Mao Hsu; Weiya Xia; Hung-Ling Wang; Ying-Nai Wang; Wei-Chao Chang; Stefan T Arold; Chao-Kai Chou; Pei-Hsiang Tsou; Hirohito Yamaguchi; Yueh-Fu Fang; Hong-Jen Lee; Heng-Huan Lee; Shyh-Kuan Tai; Mhu-Hwa Yang; Maria P Morelli; Malabika Sen; John E Ladbury; Chung-Hsuan Chen; Jennifer R Grandis; Scott Kopetz; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 9.  Endocytosis and cancer.

Authors:  Ira Mellman; Yosef Yarden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

10.  Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.

Authors:  Kamalika Saha; Matthew L Fisher; Gautam Adhikary; Daniel Grun; Richard L Eckert
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.